SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 39 400 KRW 2.47% Market Closed
Market Cap: 3.1T KRW

P/E
Price to Earnings

-61.6
Current
46.1
Median
22.3
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-61.6
=
Market Cap
3.1T KRW
/
Net Income
-50.1B KRW
Earnings Growth PEG
KR
SK Bioscience Co Ltd
KRX:302440
Average P/E: 79.6
Negative Multiple: -61.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -170 763.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
77.9
87%
0.9
US
Amgen Inc
NASDAQ:AMGN
38.6
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
278.4
187%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -227.7 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A N/A
AU
CSL Ltd
ASX:CSL
27
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
12%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.9 N/A N/A
NL
argenx SE
XBRU:ARGX
41.3
26%
1.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-27.5
2-Years Forward
P/E
-69.9
3-Years Forward
P/E
N/A